Toth Financial Advisory Corp Cassava Sciences Inc Call Options Transaction History

Toth Financial Advisory Corp

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2020 Jan 25, 2021	SELL	$6.79 - $12.25 $679 - $1,225	-100 Closed	0 $0
Q3 2020 Oct 16, 2020	BUY	$2.86 - $11.51 $286 - $1,151	100 New	100 $0

196

13.8M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.